EP1154691A4
(en)
*
|
1999-01-05 |
2004-07-07 |
Massachusetts Eye & Ear Infirm |
TARGETED ADMINISTRATION OF REGULATED RELEASE MEDICINE TO RETINA AND CHOROID THROUGH SCLEROTIC
|
US6685958B2
(en)
|
2001-04-25 |
2004-02-03 |
Insite Vision Incorporated |
Quinolone carboxylic acid compositions and related methods of treatment
|
US6239113B1
(en)
*
|
1999-03-31 |
2001-05-29 |
Insite Vision, Incorporated |
Topical treatment or prevention of ocular infections
|
US7056893B2
(en)
|
1999-03-31 |
2006-06-06 |
Insite Vision, Inc. |
Topical treatment for prevention of ocular infections
|
US6699492B2
(en)
|
1999-03-31 |
2004-03-02 |
Insite Vision Incorporated |
Quinolone carboxylic acid compositions and related methods of treatment
|
CA2383572C
(en)
|
1999-10-21 |
2007-12-11 |
Alcon Universal Ltd. |
Sub-tenon drug delivery
|
US7943162B2
(en)
*
|
1999-10-21 |
2011-05-17 |
Alcon, Inc. |
Drug delivery device
|
PL208368B1
(pl)
*
|
2000-02-29 |
2011-04-29 |
Alcon Inc |
Sposób diagnozowania jaskry
|
US7141607B1
(en)
*
|
2000-03-10 |
2006-11-28 |
Insite Vision Incorporated |
Methods and compositions for treating and inhibiting retinal neovascularization
|
EP1938799B1
(en)
*
|
2000-03-10 |
2013-05-08 |
Insite Vision Incorporated |
Compositions for treating and preventing posterior segment ophthalmic disorders and use thereof
|
US7077848B1
(en)
*
|
2000-03-11 |
2006-07-18 |
John Hopkins University |
Sutureless occular surgical methods and instruments for use in such methods
|
AU2006211555A1
(en)
*
|
2000-03-11 |
2006-10-05 |
Johns Hopkins University |
Sutureless ocular surgical methods and instruments for use in such methods
|
US7708711B2
(en)
*
|
2000-04-14 |
2010-05-04 |
Glaukos Corporation |
Ocular implant with therapeutic agents and methods thereof
|
US7867186B2
(en)
|
2002-04-08 |
2011-01-11 |
Glaukos Corporation |
Devices and methods for treatment of ocular disorders
|
US6638239B1
(en)
*
|
2000-04-14 |
2003-10-28 |
Glaukos Corporation |
Apparatus and method for treating glaucoma
|
DE60135352D1
(de)
*
|
2000-08-30 |
2008-09-25 |
Univ Johns Hopkins |
Vorrichtung zur intraokularen wirkstoffverabreichung
|
BR0115077A
(pt)
*
|
2000-11-01 |
2003-12-23 |
Merck Patent Ges Mit Beschroen |
Métodos e composições para o tratamento de doenças dos olhos
|
UA75898C2
(en)
*
|
2000-11-14 |
2006-06-15 |
Merck Patent Gmbh |
Method for prophylaxis and treatment of eye diseases using antagonist of integrin receptors
|
US6875165B2
(en)
*
|
2001-02-22 |
2005-04-05 |
Retinalabs, Inc. |
Method of radiation delivery to the eye
|
DE60225815T2
(de)
|
2001-04-07 |
2009-02-05 |
Glaukos Corp., Laguna Hills |
Glaukom-stent für die glaukom-behandlung
|
US7431710B2
(en)
|
2002-04-08 |
2008-10-07 |
Glaukos Corporation |
Ocular implants with anchors and methods thereof
|
US7488303B1
(en)
*
|
2002-09-21 |
2009-02-10 |
Glaukos Corporation |
Ocular implant with anchor and multiple openings
|
US7795218B2
(en)
|
2001-04-12 |
2010-09-14 |
Bioaxone Therapeutique Inc. |
ADP-ribosyl transferase fusion variant proteins
|
US7678065B2
(en)
*
|
2001-05-02 |
2010-03-16 |
Glaukos Corporation |
Implant with intraocular pressure sensor for glaucoma treatment
|
WO2002102241A2
(en)
*
|
2001-06-15 |
2002-12-27 |
The University Of Houston System |
Thin film optical detectors for retinal implantation and methods for making and using same
|
US7485113B2
(en)
*
|
2001-06-22 |
2009-02-03 |
Johns Hopkins University |
Method for drug delivery through the vitreous humor
|
DK1409065T3
(da)
|
2001-07-23 |
2007-05-21 |
Alcon Inc |
Oftalmisk medikamentafgivelsesanordning
|
BR0210287A
(pt)
*
|
2001-07-23 |
2005-12-13 |
Alcon Inc |
Dispositivo de administração de droga oftalmológica
|
PL207175B1
(pl)
*
|
2001-08-01 |
2010-11-30 |
Merck Patent Gmbh |
Zastosowanie inhibitorów integryny do wytwarzania kompozycji farmaceutycznych do zapobiegania i/lub terapii chorób oczu
|
US7179798B2
(en)
*
|
2001-11-16 |
2007-02-20 |
Russell R. Roby |
Methods and compositions for the treatment of pain and other hormone-allergy-related symptoms using dilute hormone solutions
|
AU2003209297A1
(en)
*
|
2002-01-18 |
2003-09-02 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for preserving the viability of photoreceptor cells
|
EP1484054B1
(en)
*
|
2002-02-22 |
2012-08-29 |
Santen Pharmaceutical Co., Ltd. |
Drug delivery system for the subconjunctival administration of fine grains
|
US7186232B1
(en)
*
|
2002-03-07 |
2007-03-06 |
Glaukoa Corporation |
Fluid infusion methods for glaucoma treatment
|
US20060094643A1
(en)
*
|
2002-07-03 |
2006-05-04 |
Yuri Svirkin |
Compositions of hyaluronic acid and methods of use
|
AU2003273339B2
(en)
*
|
2002-09-17 |
2008-08-14 |
Iscience Interventional Corporation |
Apparatus and method for surgical bypass of aqueous humor
|
CA2689424A1
(en)
*
|
2002-09-29 |
2004-04-08 |
Surmodics, Inc. |
Methods for treatment and/or prevention of retinal disease
|
US20050282814A1
(en)
*
|
2002-10-03 |
2005-12-22 |
Targegen, Inc. |
Vasculostatic agents and methods of use thereof
|
JP2004196787A
(ja)
*
|
2002-12-04 |
2004-07-15 |
Santen Pharmaceut Co Ltd |
結膜下デポによるドラッグデリバリーシステム
|
GB0228409D0
(en)
*
|
2002-12-06 |
2003-01-08 |
Thromb X Nv |
Pharmacological vitreolysis
|
US20040253293A1
(en)
*
|
2003-06-16 |
2004-12-16 |
Afshin Shafiee |
Rate controlled release of a pharmaceutical agent in a biodegradable device
|
US20050009910A1
(en)
*
|
2003-07-10 |
2005-01-13 |
Allergan, Inc. |
Delivery of an active drug to the posterior part of the eye via subconjunctival or periocular delivery of a prodrug
|
CA2522592A1
(en)
*
|
2003-07-10 |
2005-02-03 |
Alcon, Inc. |
Ophthalmic drug delivery device
|
US20050065136A1
(en)
*
|
2003-08-13 |
2005-03-24 |
Roby Russell R. |
Methods and compositions for the treatment of infertility using dilute hormone solutions
|
CA2536185C
(en)
*
|
2003-08-20 |
2012-06-26 |
Santen Pharmaceutical Co., Ltd. |
Drug delivery system by administrating fine particles to sub-tenon
|
CN1882338A
(zh)
*
|
2003-09-18 |
2006-12-20 |
马库赛特公司 |
经巩膜递送
|
EP1720608B1
(en)
*
|
2004-02-12 |
2010-11-17 |
NeoVista, Inc. |
Apparatus for intraocular brachytherapy
|
US20070166382A1
(en)
*
|
2004-03-26 |
2007-07-19 |
Kiser Patrick F |
Bioresponsive polymer system for delivery of microbicides
|
RU2006139258A
(ru)
*
|
2004-04-08 |
2008-05-20 |
Таргеджен, Инк. (US) |
Бензотриазиновые ингибиторы киназ
|
US20050239758A1
(en)
*
|
2004-04-21 |
2005-10-27 |
Roby Russell R |
Hormone treatment of multiple sclerosis
|
US20050239757A1
(en)
*
|
2004-04-21 |
2005-10-27 |
Roby Russell R |
Hormone treatment of macular degeneration
|
WO2005105133A2
(en)
*
|
2004-04-23 |
2005-11-10 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for preserving the viability of photoreceptor cells
|
CA2564806A1
(en)
*
|
2004-04-29 |
2005-11-17 |
Iscience Surgical Corporation |
Apparatus and method for surgical enhancement of aqueous humor drainage
|
US20080058704A1
(en)
*
|
2004-04-29 |
2008-03-06 |
Michael Hee |
Apparatus and Method for Ocular Treatment
|
EP2380622A1
(en)
*
|
2004-04-29 |
2011-10-26 |
iScience Interventional Corporation |
Method for ocular treatment
|
SE0401182D0
(sv)
*
|
2004-05-05 |
2004-05-05 |
Q Med Ab |
Novel use of a viscoelastic composition
|
US20060110428A1
(en)
*
|
2004-07-02 |
2006-05-25 |
Eugene Dejuan |
Methods and devices for the treatment of ocular conditions
|
US20060025390A1
(en)
*
|
2004-07-28 |
2006-02-02 |
Roby Russell R |
Treatment of hormone allergy and related symptoms and disorders
|
AU2005276974B2
(en)
|
2004-08-25 |
2012-08-02 |
Targegen, Inc. |
Heterocyclic compounds and methods of use
|
US20060046970A1
(en)
*
|
2004-08-31 |
2006-03-02 |
Insite Vision Incorporated |
Topical otic compositions and methods of topical treatment of prevention of otic infections
|
WO2006031689A2
(en)
*
|
2004-09-13 |
2006-03-23 |
Genzyme Corporation |
Multimeric constructs
|
US7553496B2
(en)
*
|
2004-12-21 |
2009-06-30 |
University Of Kentucky Research Foundation |
VEGF-A as an inhibitor of angiogenesis and methods of using same
|
US8663639B2
(en)
*
|
2005-02-09 |
2014-03-04 |
Santen Pharmaceutical Co., Ltd. |
Formulations for treating ocular diseases and conditions
|
ES2564194T3
(es)
|
2005-02-09 |
2016-03-18 |
Santen Pharmaceutical Co., Ltd. |
Formulaciones líquidas para el tratamiento de enfermedades o dolencias
|
WO2006091666A2
(en)
*
|
2005-02-23 |
2006-08-31 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for treating conditions of the eye
|
JP2008535847A
(ja)
*
|
2005-04-08 |
2008-09-04 |
サーモディクス,インコーポレイティド |
網膜下に送達するための持続放出インプラント
|
RU2007143556A
(ru)
*
|
2005-04-25 |
2009-06-10 |
ТЕВА ФАРМАСЬЮТИКАЛЗ ЮЭсЭй, ИНК. (US) |
Композиции с пролонгированным высвобождением
|
US20060292203A1
(en)
*
|
2005-06-08 |
2006-12-28 |
Targegen, Inc. |
Methods and compositions for the treatment of ocular disorders
|
US8168584B2
(en)
|
2005-10-08 |
2012-05-01 |
Potentia Pharmaceuticals, Inc. |
Methods of treating age-related macular degeneration by compstatin and analogs thereof
|
WO2007044668A2
(en)
|
2005-10-08 |
2007-04-19 |
Potentia Pharmaceuticals, Inc. |
Compstatin and analogs thereof for eye disorders
|
US8133900B2
(en)
*
|
2005-11-01 |
2012-03-13 |
Targegen, Inc. |
Use of bi-aryl meta-pyrimidine inhibitors of kinases
|
US8604042B2
(en)
*
|
2005-11-01 |
2013-12-10 |
Targegen, Inc. |
Bi-aryl meta-pyrimidine inhibitors of kinases
|
NZ592990A
(en)
*
|
2005-11-01 |
2013-01-25 |
Targegen Inc |
Bi-aryl meta-pyrimidine inhibitors of kinases
|
JP2009515655A
(ja)
*
|
2005-11-15 |
2009-04-16 |
ネオビスタ、インコーポレイテッド |
眼内近接照射療法のための方法および装置
|
BRPI0707612B8
(pt)
|
2006-02-09 |
2021-05-25 |
Macusight Inc |
vaso lacrado e formulações líquidas contidas no mesmo
|
US20070202186A1
(en)
|
2006-02-22 |
2007-08-30 |
Iscience Interventional Corporation |
Apparatus and formulations for suprachoroidal drug delivery
|
US8222271B2
(en)
|
2006-03-23 |
2012-07-17 |
Santen Pharmaceutical Co., Ltd. |
Formulations and methods for vascular permeability-related diseases or conditions
|
US8197435B2
(en)
|
2006-05-02 |
2012-06-12 |
Emory University |
Methods and devices for drug delivery to ocular tissue using microneedle
|
US7918814B2
(en)
*
|
2006-05-02 |
2011-04-05 |
Georgia Tech Research Corporation |
Method for drug delivery to ocular tissue using microneedle
|
US8030487B2
(en)
|
2006-07-07 |
2011-10-04 |
Targegen, Inc. |
2-amino—5-substituted pyrimidine inhibitors
|
JP5748407B2
(ja)
|
2006-11-10 |
2015-07-15 |
グローコス コーポレーション |
ブドウ膜強膜シャント
|
US7553486B2
(en)
*
|
2006-11-13 |
2009-06-30 |
Paul Theodore Finger |
Anti-VEGF treatment for radiation-induced vasculopathy
|
WO2008063639A2
(en)
*
|
2006-11-21 |
2008-05-29 |
Massachusetts Eye And Ear Infirmary |
Compositions and methods for preserving cells of the eye
|
US20080265343A1
(en)
*
|
2007-04-26 |
2008-10-30 |
International Business Machines Corporation |
Field effect transistor with inverted t shaped gate electrode and methods for fabrication thereof
|
US11078262B2
(en)
*
|
2007-04-30 |
2021-08-03 |
Allergan, Inc. |
High viscosity macromolecular compositions for treating ocular conditions
|
US8231892B2
(en)
*
|
2007-05-24 |
2012-07-31 |
Allergan, Inc. |
Biodegradable drug delivery system
|
US20090036827A1
(en)
*
|
2007-07-31 |
2009-02-05 |
Karl Cazzini |
Juxtascleral Drug Delivery and Ocular Implant System
|
US20100081707A1
(en)
*
|
2008-02-21 |
2010-04-01 |
Ali Robin R |
Devices and methods for delivering polynucleotides into retinal cells of the macula and fovea
|
US20100152646A1
(en)
*
|
2008-02-29 |
2010-06-17 |
Reshma Girijavallabhan |
Intravitreal injection device and method
|
AU2009256236A1
(en)
|
2008-06-04 |
2009-12-10 |
Neovista, Inc. |
Handheld radiation delivery system for advancing a radiation source wire
|
US7585291B1
(en)
*
|
2008-07-03 |
2009-09-08 |
Michael Campion |
Eye coloring systems
|
US8796443B2
(en)
|
2008-09-22 |
2014-08-05 |
Rxi Pharmaceuticals Corporation |
Reduced size self-delivering RNAi compounds
|
US20100121441A1
(en)
*
|
2008-11-10 |
2010-05-13 |
Nabil Jabbour |
Surgical implant and method
|
US20110125090A1
(en)
*
|
2008-11-13 |
2011-05-26 |
Peyman Gholam A |
Ophthalmic drug delivery system and method
|
US20100191177A1
(en)
*
|
2009-01-23 |
2010-07-29 |
Iscience Interventional Corporation |
Device for aspirating fluids
|
US8425473B2
(en)
|
2009-01-23 |
2013-04-23 |
Iscience Interventional Corporation |
Subretinal access device
|
WO2010090762A1
(en)
|
2009-02-04 |
2010-08-12 |
Rxi Pharmaceuticals Corporation |
Rna duplexes with single stranded phosphorothioate nucleotide regions for additional functionality
|
US9314421B2
(en)
*
|
2009-03-06 |
2016-04-19 |
The Hong Kong University Of Science And Technology |
Ultrasound-enhanced intrascleral delivery of macromolecules
|
US8287494B2
(en)
*
|
2009-03-23 |
2012-10-16 |
Colin Ma |
Intravitreal injection devices and methods of injecting a substance into the vitreous chamber of the eye
|
JP5342301B2
(ja)
*
|
2009-03-30 |
2013-11-13 |
三菱重工業株式会社 |
太陽光集光受熱器
|
US8632511B2
(en)
*
|
2009-05-06 |
2014-01-21 |
Alcon Research, Ltd. |
Multiple thermal sensors in a multiple processor environment for temperature control in a drug delivery device
|
US10206813B2
(en)
|
2009-05-18 |
2019-02-19 |
Dose Medical Corporation |
Implants with controlled drug delivery features and methods of using same
|
US8177747B2
(en)
*
|
2009-12-22 |
2012-05-15 |
Alcon Research, Ltd. |
Method and apparatus for drug delivery
|
JP5990103B2
(ja)
|
2009-12-23 |
2016-09-07 |
アルコン リサーチ, リミテッド |
眼科用の弁付きトロカールカニューレ
|
US8343106B2
(en)
|
2009-12-23 |
2013-01-01 |
Alcon Research, Ltd. |
Ophthalmic valved trocar vent
|
WO2011119871A1
(en)
|
2010-03-24 |
2011-09-29 |
Rxi Phrmaceuticals Corporation |
Rna interference in ocular indications
|
EP2550000A4
(en)
|
2010-03-24 |
2014-03-26 |
Advirna Inc |
RNAI COMPOUNDS OF REDUCED SIZE ADMINISTERING
|
HUE035554T2
(en)
|
2010-08-06 |
2018-05-02 |
Genzyme Corp |
VEGF antagonist compositions and their uses
|
US8217163B2
(en)
*
|
2010-09-20 |
2012-07-10 |
Biomics Biotechnologies Co., Ltd. |
Application of highly conserved domain sequences from viral genome as template to design therapeutic slirnas
|
BR112013009205A2
(pt)
|
2010-10-15 |
2016-07-26 |
Iscience Interventional Corp |
dispositivo para colocação na esclera de um olho, método para acessar o espaço supracoroidal de um olho, para acessar o espaço subretinal de um olho e para colocar um orifício dentro de um trato escleral em um olho.
|
WO2012060847A1
(en)
|
2010-11-07 |
2012-05-10 |
Targegen, Inc. |
Compositions and methods for treating myelofibrosis
|
WO2012073180A1
(en)
*
|
2010-12-02 |
2012-06-07 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Subretinal delivery of therapeutic compositions
|
US8349005B2
(en)
*
|
2011-01-03 |
2013-01-08 |
Masatoshi Murata |
Method for burying implant to choroid
|
US10245178B1
(en)
|
2011-06-07 |
2019-04-02 |
Glaukos Corporation |
Anterior chamber drug-eluting ocular implant
|
US9682144B2
(en)
|
2011-06-30 |
2017-06-20 |
Gene Signal International, Sa |
Composition comprising inhibitors of IRS-1 and of VEGF
|
GB201112145D0
(en)
|
2011-07-15 |
2011-08-31 |
Vib Vzw |
Means and methods for the treatment of pathological angiogenesis
|
EP4193907A1
(en)
|
2011-09-13 |
2023-06-14 |
Glaukos Corporation |
Intraocular physiological sensor
|
US9554940B2
(en)
|
2012-03-26 |
2017-01-31 |
Glaukos Corporation |
System and method for delivering multiple ocular implants
|
CN108949717B
(zh)
|
2012-05-11 |
2023-06-20 |
珍白斯凯尔有限公司 |
抗炎性肽及包含其的组合物
|
US10967000B2
(en)
|
2012-07-11 |
2021-04-06 |
Gemvax & Kael Co., Ltd. |
Cell-penetrating peptide, conjugate comprising same and composition comprising same
|
AU2013342275B2
(en)
|
2012-11-08 |
2017-11-09 |
Clearside Biomedical, Inc. |
Methods and devices for the treatment of ocular diseases in human subjects
|
DK2920201T3
(da)
|
2012-11-15 |
2020-04-14 |
Apellis Pharmaceuticals Inc |
Langtidsvirkende compstatin-analoger og relaterede sammensætninger og fremgangsmåder
|
US9730638B2
(en)
|
2013-03-13 |
2017-08-15 |
Glaukos Corporation |
Intraocular physiological sensor
|
WO2014152391A1
(en)
|
2013-03-15 |
2014-09-25 |
Apellis Pharmaceuticals, Inc. |
Cell-penetrating compstatin analogs and uses thereof
|
US9044508B2
(en)
|
2013-03-15 |
2015-06-02 |
Insite Vision Corporation |
Concentrated aqueous azalide formulations
|
CA3121759C
(en)
|
2013-05-03 |
2024-01-02 |
Clearside Biomedical, Inc. |
Apparatus and methods for ocular injection
|
WO2014197317A1
(en)
|
2013-06-03 |
2014-12-11 |
Clearside Biomedical, Inc. |
Apparatus and methods for drug delivery using multiple reservoirs
|
CA2912557A1
(en)
|
2013-06-07 |
2014-12-11 |
Gemvax & Kael Co., Ltd. |
Biological markers useful in cancer immunotherapy
|
KR102166545B1
(ko)
|
2013-06-21 |
2020-10-16 |
주식회사 젬백스앤카엘 |
호르몬 분비 조절제, 이를 포함하는 조성물, 및 이를 사용한 호르몬 분비 조절 방법
|
US20160279055A1
(en)
|
2013-07-22 |
2016-09-29 |
Imprimis Pharmaceuticals, Inc. |
Pharmaceutical ophthalmic compositions for intraocular administration and methods for fabricating thereof
|
JP2016525544A
(ja)
*
|
2013-07-22 |
2016-08-25 |
インプリミス・ファーマシューティカルズ・インコーポレイテッドImprimis Pharmaceuticals, Inc. |
抗菌剤及び抗炎症剤を含む眼内投与のための医薬組成物
|
US20150164882A1
(en)
|
2013-07-22 |
2015-06-18 |
Imprimis Pharmaceuticals, Inc. |
Pharmaceutical compositions for intraocular administration and methods for fabricating thereof
|
KR102494803B1
(ko)
|
2013-11-22 |
2023-02-06 |
주식회사 젬백스앤카엘 |
혈관 신생 억제 활성을 가지는 펩티드 및 이를 포함하는 조성물
|
ES2809251T3
(es)
|
2013-12-17 |
2021-03-03 |
Gemvax & Kael Co Ltd |
Composición para tratar cáncer de próstata
|
US10010447B2
(en)
|
2013-12-18 |
2018-07-03 |
Novartis Ag |
Systems and methods for subretinal delivery of therapeutic agents
|
CN106456697B
(zh)
|
2014-04-11 |
2019-12-17 |
珍白斯凯尔有限公司 |
具有纤维化抑制活性的肽和含有其的组合物
|
EP3137119B1
(en)
|
2014-04-28 |
2020-07-01 |
Phio Pharmaceuticals Corp. |
Methods for treating cancer using a nucleic acid targeting mdm2
|
ES2962532T3
(es)
|
2014-04-30 |
2024-03-19 |
Gemvax & Kael Co Ltd |
Composición para el trasplante de órganos, tejidos o células, kit y procedimiento de trasplante
|
EP3677229A1
(en)
|
2014-05-29 |
2020-07-08 |
Glaukos Corporation |
Implants with controlled drug delivery features
|
RU2710491C2
(ru)
|
2014-06-20 |
2019-12-26 |
Клиасайд Байомедикал, Инк. |
Устройство для инъекции лекарственного средства в глазную ткань и способ инъекции лекарственного средства в глазную ткань
|
USD750223S1
(en)
|
2014-10-14 |
2016-02-23 |
Clearside Biomedical, Inc. |
Medical injector for ocular injection
|
KR102413243B1
(ko)
*
|
2014-12-23 |
2022-06-27 |
주식회사 젬백스앤카엘 |
안질환 치료 펩티드 및 이를 포함하는 안질환 치료용 조성물
|
EP3263122B1
(en)
|
2015-02-27 |
2020-05-06 |
Gemvax & Kael Co., Ltd. |
Peptide for preventing hearing loss, and composition comprising same
|
US11015179B2
(en)
|
2015-07-02 |
2021-05-25 |
Gemvax & Kael Co., Ltd. |
Peptide having anti-viral effect and composition containing same
|
US11925578B2
(en)
|
2015-09-02 |
2024-03-12 |
Glaukos Corporation |
Drug delivery implants with bi-directional delivery capacity
|
US11564833B2
(en)
|
2015-09-25 |
2023-01-31 |
Glaukos Corporation |
Punctal implants with controlled drug delivery features and methods of using same
|
WO2017062879A2
(en)
|
2015-10-07 |
2017-04-13 |
Apellis Pharmaceuticals, Inc. |
Dosing regimens
|
WO2017139375A1
(en)
|
2016-02-10 |
2017-08-17 |
Clearside Biomedical, Inc. |
Ocular injection kit, packaging, and methods of use
|
EP3441082B1
(en)
|
2016-04-07 |
2023-06-21 |
Gemvax & Kael Co., Ltd. |
Peptide having effects of increasing telomerase activity and extending telomere, and composition containing same
|
JP7003110B2
(ja)
|
2016-04-20 |
2022-01-20 |
ドーズ メディカル コーポレーション |
生体吸収性眼球薬物送達デバイス
|
CA3062845A1
(en)
|
2016-05-02 |
2017-11-09 |
Clearside Biomedical, Inc. |
Systems and methods for ocular drug delivery
|
CA3072847A1
(en)
|
2016-08-12 |
2018-02-15 |
Clearside Biomedical, Inc. |
Devices and methods for adjusting the insertion depth of a needle for medicament delivery
|
CN116059313A
(zh)
|
2017-04-07 |
2023-05-05 |
阿佩利斯制药有限公司 |
给药方案以及相关组合物和方法
|
US11116625B2
(en)
|
2017-09-28 |
2021-09-14 |
Glaukos Corporation |
Apparatus and method for controlling placement of intraocular implants
|
CN110573117B
(zh)
|
2017-10-06 |
2021-10-26 |
格劳科斯公司 |
用于递送多个眼部植入物的***和方法
|
USD846738S1
(en)
|
2017-10-27 |
2019-04-23 |
Glaukos Corporation |
Implant delivery apparatus
|
JP7423070B2
(ja)
|
2018-04-06 |
2024-01-29 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
増加した溶解度および改善された薬物動態特性を有するコンプスタチンアナログ
|
CN111249034B
(zh)
*
|
2020-03-31 |
2021-11-16 |
许寅聪 |
核磁共振下可显影的后巩膜加固结构
|